218 filings
8-K
HAE
Haemonetics Corp.
9 May 24
Results of Operations and Financial Condition
6:04am
8-K
HAE
Haemonetics Corp.
1 May 24
Entry into a Material Definitive Agreement
4:12pm
8-K
HAE
Haemonetics Corp.
1 Apr 24
Haemonetics Corporation Completes Acquisition of Attune Medical
8:01am
8-K
HAE
Haemonetics Corp.
5 Mar 24
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
6:10am
8-K
HAE
Haemonetics Corp.
8 Feb 24
Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:05am
8-K
cr53it5the6va6qq
12 Dec 23
Other Events
6:09am
8-K
zshg 3vojg4qecq0obtq
2 Nov 23
Haemonetics Reports Second Quarter and First Half Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:16am
8-K/A
a4qem7
12 Oct 23
Financial Statements and Exhibits
6:10am
8-K
3iipf 3kcjcvn9
10 Oct 23
Entry into a Material Definitive Agreement
12:00am
8-K
zrz8mi cvztb9ny8
8 Aug 23
Haemonetics Reports First Quarter Fiscal 2024 Results; Updates Fiscal 2024 Guidance
6:01am
8-K
hyilndaw3 ef1h2i
7 Aug 23
Departure of Directors or Certain Officers
4:19pm
8-K
ovzo8jm1q0r6yh5b
11 May 23
Results of Operations and Financial Condition
6:05am
8-K
7kj4fwa33sofudt
7 Feb 23
Haemonetics Reports Third Quarter and Year-to-Date Fiscal 2023 Results; Updates Fiscal 2023 Guidance
6:09am
8-K
izgrwo 95mkz
7 Nov 22
Haemonetics Reports Second Quarter and First Half Fiscal 2023 Results; Updates Fiscal 2023 Guidance
6:03am
8-K
fcb1w
19 Oct 22
Departure of Directors or Certain Officers
5:15pm
8-K
no97 7g6hmxaea
10 Aug 22
Haemonetics Reports First Quarter Fiscal 2023 Results; Updates Fiscal 2023 Guidance; Announces New $300 Million Share Repurchase Authorization
12:00am
8-K
aqbd1bf
8 Aug 22
Departure of Directors or Certain Officers
5:04pm
8-K
vuqq59na0jjq6a4h4ov
1 Aug 22
Entry into a Material Definitive Agreement
4:11pm
8-K
rtjojeyq7po
16 Jun 22
Departure of Directors or Certain Officers
4:18pm
8-K
cv5kvpt
25 May 22
Departure of Directors or Certain Officers
6:14am